Consistent with this hypothesis, we have shown here that invasive BCs had a diminished expression of PSD4 when compared to pre-invasive in situ BCs and that EFA6BKO cells have a transcriptomic signature that shares several gene ontologies with signatures of progression from DCIS to IDC. The gene discussed is PSD4; the disease is ductal breast carcinoma in situ.